Litigation concerning advertising and patents between nicotinamide riboside supplement firms ChromaDex Corp. and Elysium Health Inc. continue after a California federal court jury renders a split decision on ChromaDex’ complaint that Elysium didn’t pay for supplies it provided.
The jury in the US District Court for Central California found both parties breached contracts: Elysium failed to pay for...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?